Mezavant is a medicine containing the active ingredient(s) mesalazine. On this page you will find out more about Mezavant, including side effects, age restrictions, food interactions and whether the medicine is subsidised by the government on the pharmaceutical benefits scheme (PBS)
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional. healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.
Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions.
Active ingredient in this medicine: mesalazine
Information for medicine and pack size:
Mezavant 1.2 g modified release tablet, 120
Consumer Medicine Information leaflet:
This leaflet may also be found inside the medicine package. It contains information on side effects, age restrictions and other useful data.
What this medicine is for
For the induction and maintenance of remission in patients with mild to moderate, active ulcerative colitis.
Table of characteristics
Red-brown, ellipsoidal, film-coated tablet, S476 debossed on one side
Images are the copyright of the Pharmacy Guild of Australia
|Dosage Form||Tablet, modified release|
|Route of administration||Oral|
12 tablets: Prescription Only Medicine, or Prescription Animal Remedy
120 tablets: Prescription Only Medicine, or Prescription Animal Remedy
60 tablets: Prescription Only Medicine, or Prescription Animal Remedy
There is one type of pack available.
Pack type 1
|Storage temperature||Store below 25 degrees Celsius|
|Storage conditions||No information available|
|Life time||2 Years|
We were unable to verify that this medicine is available on the PBS (Pharmaceutical Benefits Scheme). Please consult your pharmacist if you need further information
The PBS provides a list of government subsidised medicines available to be dispensed to patients. Further information can be found on the Pharmaceutical Benefits Scheme website.
Is this medication banned in sport?
Check if you can use your medicine whilst playing sport. Search the Australian Sports Anti-Doping Authority (ASADA) database that provides information about the prohibited status of specific medications and/or the active ingredient based on the current World Anti-Doping Agency (WADA) Prohibited List.
Found 3 results
Mezavant Prolonged release tablets - myDr.com.au
Mezavant Prolonged release tablets - Consumer Medicines Information leaflets of prescription and over-the-counter medicines
Read more on myDr – Consumer Medicine Information website
Mezavant Gastro-Resistant Prolonged-Release Tablets | myVMC
Mezavant is used to treat mild to moderate active ulcerative colitis. Mesalazine, the active ingredient, is released slowly into the colon.
Read more on myVMC – Virtual Medical Centre website
Ulcerative colitis: treatment - myDr.com.au
Treatment of ulcerative colitis will depend on the severity of the disease, the effect the symptoms are having on your daily life and whether you are in remission or are having a flare-up.
Read more on myDr website
Found 0 results